When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APLS - Regeneron's pozelimab shows positive effect in PNH study
Apellis Pharmaceuticals Inc.
Topline data from an initial six-subject cohort in an open-label, single-arm Phase 2 clinical trial evaluating Regeneron Pharmaceuticals' (NASDAQ:REGN) pozelimab (REGN3918) in patients with paroxysmal nocturnal hemoglobinuria (PNH) showed a positive effect.
More news on: Regeneron Pharmaceuticals, Inc., Akari Therapeutics, Plc, Achillion Pharmaceuticals, Inc., Healthcare stocks news,